GSK's Zantac Woes Gave Investors Heartburn, Suit Says
By Katryna Perera · February 6, 2025, 4:50 PM EST
The maker of heartburn and acid reflux relief tablet Zantac has been hit with a shareholder suit in Pennsylvania federal court alleging that the company suffered stock price losses after it...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login